Bora Pharmaceuticals Co., Ltd.

NT$399.50As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6472Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 37.93%
Div yield 2.50%
ROE 12.05%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.46
PE TTM 50.95
TSR TTM (33.95%)
Mkt cap NT$50.85B
ROIC 6.97%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$488
22.20%
68.53%
Hold 6|8|10|11|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
6.25
6.14
6.17
5.97
22.82%
9.78%
1.46%
2.08%
RevenueNT$B
6.131
6.312
6.467
6.357
10.42%
9.43%
12.39%
9.11%
Peers (US$1.536B)
Cap (US$)
PE
673.7M
22.18x
Capital
TTM
5Y
10Y
Leveragex
0.492
0.116
0.108
EBIT/Intx
0.900
0.051
0.061
Own earn%
(32.26)
168.59
155.23
Sh yield%
32.16
7.17
10.08
Owners
Insiders/Inst%
8.71
37.84
Short interest%
2.21
SBC / revenue%
3.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
24–28
$1 testx
—
Incr. ROIC%
1